Wednesday, February 15, 2012

iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net Hub

Severna Park, MD — February 15, 2012 — Medical technology company iSonea Ltd. (ASX: ISN; OTCQX: ISOAY), announced that it will design and market a home and mobile asthma monitoring platform with global telecommunications corporation Qualcomm Life Inc.,™ a wholly owned subsidiary of Qualcomm Incorporated (NASDAQ: QCOM). The new technology will combine iSonea’s proprietary Acoustic Respiratory Monitoring (ARM)™ devices and mobile health asthma management systems with Qualcomm’s 2net™ platform.

The integration will automatically and securely link patient asthma symptom and trend monitoring data to a cloud-based portal for physicians and caregivers, to improve asthma management and outcomes.

The effort leverages Qualcomm Life's 2net Hub, a plug-and-play connectivity gateway to the cloud-based 2net platform data server, to collect and transmit patient health data from iSonea’s monitoring devices. The technology will ultimately allow physicians to securely access patient monitoring data, review treatment progress and medication adherence and adjust patient action plans accordingly. Family and caregivers will be able to view trends for reassurance about patient care.

“Asthma is a widespread and growing condition that affects 300 million people worldwide and represents a major healthcare cost burden,” said Michael J. Thomas, Chief Executive Officer of iSonea Limited. “With our smartphone platform and Qualcomm’s end-to-end wireless systems expertise, we will provide asthma patients with the ability to monitor and report breathing distress symptoms triggered by environmental factors, as well as their response to treatment. Better daily monitoring can lead to improved medication compliance, lower healthcare costs and improved chronic management of asthma. For patients or family members, better monitoring also means more peace of mind.”

Qualcomm’s wireless solutions will enable iSonea’s ARM-based mobile asthma management products, in a cost-effective and scalable manner, to:

• Connect and securely transmit data to a cloud-based site for analysis;
• Provide protected data access to physicians, caregivers, family and patients; and
• Give consumers an easy-to-use dashboard to view and manage their asthma trends.

iSonea’s Senior Vice President of Operations Steve Tunnell added, “Qualcomm understands the need for wireless solutions that will link with self-monitoring devices to allow data sharing in the new ‘smart home.’ Integrating our acoustic respiratory monitoring sensors and software with the Qualcomm 2net Hub will help people share their asthma management data with physicians, family and caregivers, alerting them to critical changes.”

About iSonea Limited

iSonea Limited (ASX:ISN; OTCQX:ISOAY) is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the management of chronic, costly respiratory disorders such as asthma and COPD. By leveraging iSonea’s proprietary Acoustic Respiratory Monitoring™ (ARM) technology with its AsthmaSense™ mobile applications, iSonea is turning smartphones into medical devices--enabling anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action. iSonea’s ARM devices have been cleared for use by the U.S. Food and Drug Administration, the Australian TGA and the European Union CE. For more information, please visit

About Qualcomm

Qualcomm (NASDAQ: QCOM) is an American global telecommunications company which designs, manufactures and markets digital wireless telecommunications products and services based on its code division multiple access (CDMA) technology and other technologies. It is headquartered in San Diego, California, USA.

No comments:

Post a Comment